Found 49 matching trials
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS) PHASE2 The primary objectives of the study are to evaluate the safety of BIIB061 v...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®. PHASE4 This study is designed to compare injection site reactions with or without ...
Show More Location
Multiple Locations
Learn More & Join Trial
Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate PHASE4 The purpose of this study is to assess the effect of Diclofenac Sodium Topi...
Show More Location
MS Center at Evergreen Healthcare
Learn More & Join Trial
Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone® PHASE4 The primary objective of this study is to compare patient medication satisf...
Show More Location
Teva Investigational Site 13485
Learn More & Join Trial
Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness PHASE4 This open-label extension study will evaluate the long-term safety of glati...
Show More Location
Teva Investigational Site 009
Learn More & Join Trial
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. PHASE4 This study is designed to compare injection skin (injection site) reactions...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis PHASE3 To determine if treatment with BG00012 can decrease the number of MS relaps...
Show More Learn More & Join Trial
Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis N/A The purpose of this study is to determine if certain drugs commonly used to...
Show More Location
General Clinical Research Center
Learn More & Join Trial
An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) PHASE3 This study will investigate the efficacy, safety and tolerability of a new ...
Show More Location
Teva Investigational Site 10192
Learn More & Join Trial
Safety of New Formulation of Glatiramer Acetate PHASE3 The purpose of this study is to compare pain associated with injections and...
Show More Location
Multiple Locations
Learn More & Join Trial